{"id":"W4406227864","doi":"10.1080/14796694.2024.2439178","title":"Asciminib versus bosutinib following 2 or more prior therapies in chronic myeloid leukemia: a plain language summary of the ASCEMBL study","year":2025,"lang":"en","type":"article","venue":"Future Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Bosutinib; Medicine; Myeloid leukemia; Oncology; Side effect (computer science); Internal medicine; Tyrosine-kinase inhibitor; Drug; Imatinib; Pharmacology; Nilotinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01238822,0.0008466979,0.003252858,0.0007706471,0.0004842752,0.002880269,0.0007055905,0.002175106,0.01715009],"category_scores_gemma":[0.0207666,0.0004172376,0.006329666,0.001330257,0.000341467,0.001486263,0.0007001961,0.003577565,0.003021711],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001347255,"about_ca_system_score_gemma":0.001747648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001033033,"about_ca_topic_score_gemma":0.001606384,"domain_scores_codex":[0.9927226,0.004663353,0.001306417,0.0002498218,0.0007935265,0.0002644393],"domain_scores_gemma":[0.9803843,0.01150516,0.003731339,0.0004627217,0.002769792,0.001146709],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.3611926,0.003969599,0.008852193,0.07364971,0.02069536,0.0003803498,0.0004436137,0.0007140384,0.00169503,0.001615554,0.1700132,0.3567788],"study_design_scores_gemma":[0.3075215,0.1292621,0.06364373,0.0645902,0.04031989,0.0008576676,0.001060699,0.001009926,0.001764187,0.003038761,0.3864734,0.000457943],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.09841635,0.7300269,0.002766666,0.06766305,0.02434771,0.01153976,0.03140656,0.0002183822,0.03361462],"genre_scores_gemma":[0.3610117,0.4090018,0.007697755,0.09560213,0.05002506,0.0263959,0.02390765,0.0003297375,0.02602823],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.01715009,"threshold_uncertainty_score":0.065516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01723574195103834,"score_gpt":0.3434522840867526,"score_spread":0.3262165421357143,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}